So far, elevated TKS5 expression has been demonstrated in lung adenocarcinoma [122], glioblastoma cells [119], breast cancer, melanoma cells [120], and keratocystic odontogenic tumor samples [123], where it is primarily correlated with the invasive phenotypes. Here, SH3PXD2A is linked to lung adenocarcinoma.